sNIPPV Versus NIV-NAVA in Extremely Premature Infants (EASYNNEO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04068558|
Recruitment Status : Recruiting
First Posted : August 28, 2019
Last Update Posted : January 13, 2020
The aim of this study is to demonstrate a significant decrease in asynchrony with NIV-NAVA using the Servo n ventilator (Getinge, Sweden), as compared to abdominal triggered (Graseby capsule) synchronized nasal intermittent positive pressure ventilation (sNIPPV) using the Infant Flow CPAP device (Care Fusion, USA).
All of the data obtained can be used to develop a large-scale study aimed at reducing the rate of re-intubation in the study population (pilot study). In fact, the re-intubation criteria for extremely premature children are based on clinical criteria (desaturations, apnea, signs of respiratory control) and paraclinical criteria (FiO2, Potential hydrogen (pH), PCO2).
The results of this pilot study will help to develop an adapted methodology and to calculate a sample size to compare the 2 modes of NIV to the test on a clinical criterion: the rate of re-intubation after extubation, which is classically high in these patients.
|Condition or disease||Intervention/treatment||Phase|
|Premature Birth Ventilator Lung; Newborn||Device: VNI-NAVA/sNIPPV Device: sNIPPV/VNI-NAVA||Not Applicable|
The use of non-invasive ventilation has significantly reduced morbidity and mortality in premature newborns by reducing the pulmonary lesions caused by invasive ventilation. Currently, variable flow continuous positive airway pressure (CPAP) devices, such as the infant flow® driver, are considered more efficient than constant flow pressure sources. Nasal intermittent positive pressure ventilation, as compared to CPAP, might reduce the extubation failure rate, but has no impact on mortality or bronchopulmonary dysplasia. However, data is lacking on the interest of synchronization and on the effect of the different available interfaces (prongs, masks, cannulas). In addition, the ventilatory characteristics (high respiratory rate and low inspiratory effort) of the premature infant increase the risk of asynchrony between the patient and the ventilator, which is a major cause of poor tolerance for this type of ventilation.
NAVA (neurally adjusted ventilatory assist) is a recent ventilatory mode that offers proportional assistance to respiratory work based on the measured electrical activity of the diaphragm via oesophageal electrodes. It thus allows a regulation of inspiratory pressures and time by the patient him/herself. The physiological effects of NAVA have been primarily described in intubated neonates and studies have shown a significantly improved synchronization and significantly decreased inspiratory pressures in patients ventilated with NAVA compared to intermittent controlled ventilatory support. However, the currently available evidence is limited and no beneficial effect on morbidity or mortality has been identified so far .
There are few studies on noninvasive NAVA (NIV-NAVA) conducted exclusively in neonates, most of which included a limited number of patients. Only one study to date compared NIV-NAVA to another synchronized NIV mode (NIV pressure support) using the Servo-i ventilator. This prospective crossover study found a significant decrease in peak inspiratory pressure (PIP), FiO2, frequency and length of desaturations in the NIV-NAVA group.
Decreased asynchrony has been observed during NIV-NAVA as compared to pressure-support NIV In adult patients and in 6 children hospitalized in the Pediatric ICU (median age 18 months).
In premature neonates, variable flow CPAP is preferentially used. Synchronized intermittent positive pressure can be delivered using a variable flow device and a Graseby abdominal capsule. Since variable flow CPAP is considered the most efficient pressure generator, it is legitimate to compare synchronization performance of the variable flow synchronized nasal intermittent positive pressure ventilation (sNIPPV) to NIV-NAVA. This comparison has never been performed so far, to our knowledge.
We hypothesize that synchronization will be markedly improved with NIV-NAVA as compared to sNIPPV.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||14 participants|
|Intervention Model:||Crossover Assignment|
|Intervention Model Description:||Randomized crossover trial in the Neonatal Intensive Care Unit|
|Masking:||None (Open Label)|
|Official Title:||Synchronized Nasal Intermittent Positive Pressure Ventilation Versus Noninvasive Neurally Adjusted Ventilatory Assist Ventilation in Extremely Premature Infants: a Randomized Crossover Trial|
|Actual Study Start Date :||December 9, 2019|
|Estimated Primary Completion Date :||September 2020|
|Estimated Study Completion Date :||October 2020|
Ventilation of the child non-invasive ventilation (VNI) NAVA then sNIPPV
Ventilation of the child in NIV-NAVA for 2 hours then ventilation of the child in sNIPPV for two hours. The ventilation periods consist of one hour of wash-out and one hour of data collection
Ventilation of the child sNIPPV then non-invasive ventilation (VNI) NAVA
Ventilation of the child in sNIPPV for 2 hours then ventilation of the child in NIV-NAVA for two hours. The ventilation periods consist of one hour of wash-out and one hour of data collection
- Asynchrony index [ Time Frame: 4 hours ]Asynchrony index as previously defined in the literature using the following parameters: Ineffective effort (IE): presence of an inspiratory electromyographic signal not followed by pressurization; Late cycling (LC): a cycle with an inspiratory time greater than twice the patient's neural inspiratory time; Premature cycling (PC): a cycle with an inspiratory time shorter than the the neural inspiratory time; Double triggering (DT): two ventilator-delivered cycles triggered by one neural inspiration; Auto triggering (AT): a cycle delivered by the ventilator in the absence of EAdi signal.
- Components of the Asynchrony index [ Time Frame: 4 hours ]Each component of the Asynchrony index will be compared between the 2 ventilatory modes.
- Mean change in electric activity of the diaphragm (Edi) [ Time Frame: 4 hours ]Analyze as exploratory data of Mean delta Edi (max-min value) in NIV NAVA vs sNIPPV
- Apnoea [ Time Frame: 4 hours ]Analyze as exploratory data of Frequency of apnoea
- Desaturations [ Time Frame: 4 hours ]Analyze as exploratory data of Frequency of desaturations below 80%
- Bradycardia [ Time Frame: 4 hours ]Analyze as exploratory data of Frequency of bradycardia < 100 bpm
- ComfortNeo score [ Time Frame: 4 hours ]Analyze as exploratory data of Comfort Neo score assessed by the nurse before and after each ventilation period
- transcutaneous PCO2 [ Time Frame: 4 hours ]TcPCO2 modeling over time and comparison between NIV Nava and sNIPPV
- Nava level [ Time Frame: 1 hour ]Description of Nava levels used during NIV Nava
- Inspiratory pressure during sNIPPV [ Time Frame: 1 hour ]Description of inspiratory pressures used during sNIPPV
- Bag-mask ventilation or re-intubation [ Time Frame: 4 hours ]Frequency of bag-mask ventilation or re-intubation
- Re-intubation within 7 days [ Time Frame: 7 days ]Frequency of re-intubation within 7 days of randomization
- Fi02 [ Time Frame: 4 hours ]FiO2 changes over time during NIV NAVA and sNIPPV
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04068558
|Contact: Camille JUNG, MD||01 57 02 22 email@example.com|
|Centre Hospitalier Intercommunal de Créteil||Recruiting|
|Créteil, France, 94000|
|Contact: Xavier Durrmeyer, MD +33673732017 firstname.lastname@example.org|
|Principal Investigator: Xavier Durrmeyer, MD|
|Sub-Investigator: Claude Danan, MD|
|Sub-Investigator: Charles Treussart, MD|
|Sub-Investigator: Fabrice Decobert, MD|